Survival in Myelofibrosis Patients After Allogeneic Hematopoietic Stem Cell Transplantation in Five Centers in France

clinical trial

Survival in Myelofibrosis Patients After Allogeneic Hematopoietic Stem Cell Transplantation in Five Centers in France is …
instance of (P31):
clinical trialQ30612

External links are
P3098ClinicalTrials.gov IDNCT04282421

P582end time2017-12-31
P921main subjectgraft-versus-host diseaseQ1194520
P1050medical conditionchronic idiopathic myelofibrosisQ3857106
P2899minimum age18
P1132number of participants58
P1813short nameSYMFASCT
P580start time2007-01-01
P8363study typeobservational studyQ818574
P1476titleSurvival in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation for Myelofibrosis in Five French Centers

Search more.